KIR3DL1 and hepatocellular carcinoma: Next, we stratified patients with chronic hepatitis C into younger (<65 years) and older (≥65 years) groups to examine the clinical characteristics and associations of HLA and KIR genes with HCC development according to age (Figure 3A and 3B).